Halozyme Therapeutics (NASDAQ: HALO) announced the completion of its acquisition of Elektrofi, a biopharmaceutical company specializing in ultra-high concentration microparticle ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE